Nova Eye Earnings Estimate

EYE Stock   0.19  0.01  5.56%   
By analyzing Nova Eye's earnings estimates, investors can diagnose different trends across Nova Eye's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Nova Eye Medical is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Nova Eye is projected to generate -0.01 in earnings per share on the 30th of June 2024. Nova Eye earnings estimates show analyst consensus about projected Nova Eye Medical EPS (Earning Per Share). It derives the highest and the lowest estimates based on Nova Eye's historical volatility. Many public companies, such as Nova Eye, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Nova Eye's earnings estimates, investors can diagnose different trends across Nova Eye's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to drop to about 15.5 M in 2025
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Nova Eye Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Nova Eye Earnings per Share Projection vs Actual

About Nova Eye Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Nova Eye earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Nova Eye estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Nova Eye fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-35.3 M-33.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nova Stock Analysis

When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.